0.060
0.00 (0.00%)
| Penutupan Terdahulu | 0.060 |
| Buka | 0.060 |
| Jumlah Dagangan | 121,116 |
| Purata Dagangan (3B) | 185,577 |
| Modal Pasaran | 26,813,578 |
| Harga / Jualan (P/S) | 3.35 |
| Harga / Buku (P/B) | 2.65 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Aug 2024 |
| Margin Keuntungan | 1.97% |
| Margin Operasi (TTM) | -0.16% |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 131.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 33.81% |
| Nisbah Semasa (MRQ) | 1.51 |
| Aliran Tunai Operasi (OCF TTM) | 1.39 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.23 M |
| Pulangan Atas Aset (ROA TTM) | -2.30% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (AU) | Bercampur | Bercampur |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | RESONANCE FPO [RHT] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.13 |
|
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 35.98% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |